SCHEMBL10068014

SCHEMBL10068014

CC(C1C2CN(C(=O)OC(C)(C)C)C[C@@H]21)S(C)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.43
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GPR119 Q8TDV5 6/20 0.37
HPGD P15428 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
JAK3 P52333 1/20 0.35
RECQL P46063 1/20 0.35
EPHX1 P07099 1/20 0.35
DDB1 Q16531 1/20 0.34
CRBN Q96SW2 1/20 0.34
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17173181 0.82 NR1H2 (0.49) NR1H2USP2SMN1; SMN2HPGDNPC1
SCHEMBL10068011 0.81 NR1H2 (0.47) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL18082348 0.78 NR1H2 (0.58) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL16759817 0.78 NR1H2 (0.58) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL31444567 0.78 NR1H2 (0.47) NR1H2USP2SMN1; SMN2HPGDALDH1A1
SCHEMBL29215824 0.74 NR1H2 (0.48) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL30241638 0.74 NR1H2 (0.44) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL30241467 0.74 NR1H2 (0.48) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL28854725 0.74 NR1H2 (0.44) NR1H2USP2SMN1; SMN2GPR119HPGD
SCHEMBL10739134 0.74 NR1H2 (0.50) NR1H2USP2SMN1; SMN2GPR119HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed